Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II

Hypertension

Volumn 45, Issue 5, 2005, Pages 860-866

  Kimura, Shoji ^a   Zhang, Guo Xing ^a   Nishiyama, Akira ^a   Shokoji, Takatomi ^a   Yao, Li ^a   Fan, Yu Yan ^a   Rahman, Matlubur ^a   Suzuki, Takeo ^a   Maeta, Hajime ^a   Abe, Youichi ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Angiotensin; Antioxidants; Free radicals; Heart

Indexed keywords

5 HYDROXYDECANOIC ACID; ANGIOTENSIN; APOCYNIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STRESS ACTIVATED PROTEIN KINASE; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG INFUSION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

ACETOPHENONES; ANGIOTENSIN II; ANIMALS; CARDIOTONIC AGENTS; DECANOIC ACIDS; ENZYME ACTIVATION; ENZYME INHIBITORS; HYDROXY ACIDS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; LIPID PEROXIDATION; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NADPH OXIDASE; PHAGOCYTES; RATS; REACTIVE OXYGEN SPECIES; SUPEROXIDES;

EID: 20944442518     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000163462.98381.7f     Document Type: Article

References (34)

1. ATP channels: role in cardioprotection. Cardiovasc Res. 2002;55:429-437.
2. Sasaki N, Murata M, Guo Y, Jo S-H, Ohler A, Akao M, O'Rourke B. Xiao R-P, Bolli R, Marban E. MCC-134, a single pharmacophore, opens surface ATP-sensitive potassium channels, blocks mitochondrial ATP-sensitive potassium channels, and suppresses preconditioning. Circulation. 2003;107:1183-1188.
3. ATP channels. Circ Res. 2001;89:273-278.
4. ATP channels triggers the preconditioned state by generating free radicals. Circ Res. 2000;87:460-466.
5. Forbes RA, Steenbergen C, Murphy E. Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ Res. 2001;88:802-809.
6. Andre K, Chen N, Chandel NS, Shao Z, Schumacker PT. Mitochondrial ROS initiate phosphorylation of p38 MAP kinase during hypoxia in cardiomyocytes. Am J Physiol Lung Cell Mol Physiol 2002;282: L1324-L1329.
7. Armstrong SC, Delacey M, Ganote CE. Phosphorylation state of hsp27 and p38 MAPK during preconditioning and protein phosphatase inhibitor protection of rabbit cardiomyocytes. J Mol Cell Cardiol. 1999;31:555-567.
8. Nakano A, Baines CP, Kim SO, Pelech SL, Downey JM. Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart. Evidence for involvement of p38 MAPK. Circ Res. 2000;86:144-151.
9. Becker LB. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res. 2004;61:461-470.
10. Griendling KK, Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept. 2000;91:21-27.
11. Zhang G-X, Kimura S, Nishiyama A, Shokoji T, Rahman M, Abe Y. ROS during the acute phase of Ang II hypertension participates in cardiovascular MAPK activation but not vasoconstriction. Hypertension. 2004;43:117-124.
12. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000;86:494-501.
13. phox in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension. 2002;40:511-515.
14. phox subunit. J Biol Chem. 2003;278:12094-12100.
15. phox-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation. 2002;105:293-296.
16. Liu Y, Tsuchida A, Cohen MV, Downey JM. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol. 1995;27:883-892.
17. ATP channel. Cardiovasc Res. 2002;55:576-582.
18. Shinomiya K, Fukunaga M, Kiyomoyto H, Mizushige K, Tsuji T, Noma T, Ohmori K, Kohno M, Senda S. A role of oxidative stress-generated eicosanoid in the progression of arteriosclerosis in type 2 diabetes mellitus model rats. Hypertens Res. 2002;25:91-98.
19. Wada K, Kamisaki Y, Nakamoto K, Itoh T. Effect of cystathionine as a scavenger of superoxide generated from human leukocytes or derived from xanthine oxidase in vitro. Eur J Pharmacol. 1996;296:335-340.
20. Li Y, Zhu H, Trush MA. Detection of mitochondria-derived reactive oxygen species production by the chemilumigenic probes lucigenin and luminol. Biochim Biophys Acta. 1999;1428:1-12.
21. Forman HJ, Torres M. Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am J Respir Crit Care Med. 2002;166:S4-S8.
22. ATP channels in pigs. Am J Physiol Heart Circ Physiol. 2002;283:H1538-H1544.
23. ATP channel. Am J Physiol Heart Circ Physiol. 2003;284: H299-H308.
24. Sato T, Sasaki N, O'Rourke B, Marban E. Adenosine primes the opening of mitochondrial ATP-sensitive potassium channels: a key step in ischemic preconditioning? Circulation. 2000;102:800-805.
25. ATP channel opening and leads to cardioprotection. Am J Physiol Heart Circ Physiol. 2004;286:H468-H476.
26. Dandona P, Kumar V, Aljada A, Ghanim H, Syed T, Hofmayer D, Mohanty P, Tripathy G, Garg R. Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-kappa B, in mononuclear cells of normal subjects: evidence of an anti-inflammatory action. J Clin Endocrinol Metab. 2003;88:4496-4501.
27. Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci. 2003;24:471-478.
28. Zhang DX, Chen YF, Campbell WB, Zou AP, Gross GJ, Li PL. Characteristics and superoxide-induced activation of reconstituted myocardial mitochondrial ATP-sensitive potassium channels. Circ Res. 2001;89:1177-1183.
29. Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med. 2000;192:1001-1014.
30. Izumiya Y, Kim S, Izumi Y, Yoshida K, Yoshiyama M, Matsuzawa A, Ichijo H, Iwao H. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling. Circ Res. 2003;93:874-883.
31. Iijima Y, Laser M, Shiraishi H, Willey CD, Sundaravadive B, Xu L, McDermott PJ. c-Raf/MEK/ERK pathway controls protein kinase C-mediated p70S6K activation in adult cardiac muscle cells. J Biol Chem. 2002;277:23065-23075.
32. 2-terminal kinases. J Clin Invest. 1999;104:391-398.
33. Qin F, Shite J, Liang C. Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways. Am J Physiol Heart Circ Physiol. 2003;285:H822-H832.
34. ATP channels, and ERK. Am J Physiol Heart Circ Physiol. 2004;286:H1433-H1440.